Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

Healthcare Biotechnology

SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

Add To Watchlist

NDAQ:SCYX - Post Discussion

SCYNEXIS Inc > scyx needs to find financial backing

View:

Post by Tcheck on Mar 11, 2020 3:51pm

scyx needs to find financial backing

it will stop our headache

226

Comment

Comment by dmacd on Jun 26, 2020 10:24pm

New marketing guy was a disaster at Viveve. He spent way more than his team earned and perpetually under delivered. I am puzzled by this appointment.

113

Comment

Comment by dmacd on Apr 01, 2021 2:18pm

I have seen some good moves lately by management. New guy from viveve seems to have learned his lesson. Dilution needs to stop now. Enough already. I doubled down recently with a 5x target by 2023. Exciting times ahead.

Comment

Comment by JonathanJSmith on Apr 27, 2021 10:26am

Dude, They have enough money to last until 2023 ($93MM) according to recent filings. Currently, they have ~20MM shares outstanding; fully diluted, this number is ~40MM however, that includes another $105MM in cash for those 20MM shares (which they've yet to receive). Effectively, they have access to over $200MM. Furthermore, with their drug about to be approved (fingers crossed as I am long), ...more

101

Comment

SCYNEXIS Inc